Literature DB >> 22297145

Prevalence of anti-Toxoplasma antibodies in patients with autoimmune diseases.

Yinon Shapira1, Nancy Agmon-Levin, Carlo Selmi, Jana Petríková, Ori Barzilai, Maya Ram, Nicola Bizzaro, Gabriele Valentini, Marco Matucci-Cerinic, Juan-Manuel Anaya, Bat-sheva Porat Katz, Yehuda Shoenfeld.   

Abstract

The identification of etiological factors in the induction of autoimmunity has remained elusive despite an enormous effort at dissection of the molecular structure of the target antigens and effector mechanisms. One characteristic feature of autoantigens is their repetitive structure as well as their conservation and evolution. Toxoplasma (T.) gondii is a primitive protozoan. We hypothesized that patients with autoimmune disease would have broad reactions against Toxoplasma antigens based on autoantigen conservation. To address this issue, we assessed serologic evidence of reactivity to Toxoplasma gondii along with a large profile of autoantibodies in patients with various autoimmune diseases (AID). We included sera of 1514 patients with 11 different AID collected from referral centers in Europe and Latin America as well as from 437 geographically matched controls, for the prevalence of anti Toxoplasma antibodies (ATxA) IgG and IgM and serum autoantibodies utilizing the BioPlex 2200 system (Bio- Rad Laboratories, USA). Serum ATxA IgG were positive in 42% of patients with AID versus 29% of controls (p < 0.0001). Among Europeans, ATxA IgG were associated with anti-phospholipid syndrome (APS; p < 0.0001), cryoglobulinemia (p < 0.0001), ANCA-associated vasculitides (p < 0.01), autoimmune thyroid diseases (p < 0.0001), systemic sclerosis (SSc; p < 0.0001) and rheumatoid arthritis (RA; p < 0.0001). Of note, Latin American RA sera exhibited similar frequency of ATxA IgG as controls. ATxA IgM were more prevalent in European patients with APS (p < 0.01), SSc (p < 0.05) and inflammatory bowel disease (IBD, p < 0.05) than in controls. Further, in AID patients the presence of ATxA correlated with autoantibodies characteristic of APS (anti- cardiolipin, B2GPI, complex of cardiolipin- B2GPI, prothrombin, phosphatydilethanolamine), and of SSc (anti-centromere, Scl-70). Our findings suggest that T. gondii may contribute to the pathogenesis of AID. This interaction may depend on or explain observed geoepidemiological variance in AID.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22297145     DOI: 10.1016/j.jaut.2012.01.001

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  24 in total

1.  The common parasite Toxoplasma gondii induces prostatic inflammation and microglandular hyperplasia in a mouse model.

Authors:  Darrelle L Colinot; Tamila Garbuz; Maarten C Bosland; Liang Wang; Susan E Rice; William J Sullivan; Gustavo Arrizabalaga; Travis J Jerde
Journal:  Prostate       Date:  2017-05-12       Impact factor: 4.104

Review 2.  The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.

Authors:  Ying Sun; Weici Zhang; Baosen Li; Zhengsheng Zou; Carlo Selmi; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

3.  Fetomaternal and Pediatric Toxoplasmosis.

Authors:  Helieh S Oz
Journal:  J Pediatr Infect Dis       Date:  2017-12       Impact factor: 0.293

Review 4.  Severe polymyositis due to Toxoplasma gondii in an adult immunocompetent patient: a case report and review of the literature.

Authors:  G Cuomo; V D'Abrosca; V Rizzo; S Nardiello; G La Montagna; G B Gaeta; G Valentini
Journal:  Infection       Date:  2013-04-01       Impact factor: 3.553

5.  The Relation between Toxocariasis and Toxoplasmosis co-infection and the presence of Rheumatoid Factor (RF) in people with hydatidosis in Southwestern Iran, from 2013 to 2018.

Authors:  Maryam Fasihi Karami; Abdollah Rafiei; Omid Raiesi; Muhammad Getso; Elham Akhlaghi; Pantea Jalali; Mahdi Shayanfard; Ehsan Beigzadeh; Shirin Khodabakhsh Arbat; Zahra Mirabedini; Vahid Raissi
Journal:  J Parasit Dis       Date:  2019-03-19

Review 6.  Molecular mimicry and autoimmune thyroid disease.

Authors:  Salvatore Benvenga; Fabrizio Guarneri
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

7.  Anti-Toxoplasma antibodies in Egyptian rheumatoid arthritis patients.

Authors:  Abeer A El-Henawy; Eman Abdel Razek Hafez; Nairmen Nabih; Naglaa M Shalaby; Mervat Mashaly
Journal:  Rheumatol Int       Date:  2017-03-20       Impact factor: 2.631

8.  Chronic Toxoplasma gondii infection enhances susceptibility to colitis.

Authors:  Iti Saraav; Luisa Cervantes-Barragan; Philipp Olias; Yong Fu; Qiuling Wang; Leran Wang; Yi Wang; Matthias Mack; Megan T Baldridge; Thaddeus Stappenbeck; Marco Colonna; L David Sibley
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-07       Impact factor: 11.205

9.  Toxoplasma gondii: bystander or cofactor in rheumatoid arthritis.

Authors:  Svetlana Fischer; Nancy Agmon-Levin; Yinon Shapira; Bat-Sheva Porat Katz; Eduard Graell; Ricard Cervera; Ljudmila Stojanovich; Jose A Gómez Puerta; Raimon Sanmartí; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 10.  Autoimmunity in 2012.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.